Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study.

<h4>Aim</h4>The aim of this study was to assess the prevalence and patterns of exposure to antidepressants before, during and after pregnancy in a cohort including all pregnant women in Denmark between 1997 and 2010.<h4>Methods</h4>We performed a retrospective cohort study in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Espen Jimenez-Solem, Jon Trærup Andersen, Morten Petersen, Kasper Broedbaek, Nadia Lyhne Andersen, Christian Torp-Pedersen, Henrik Enghusen Poulsen
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f4bfcdc76a214710ba69a7678e2a8959
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f4bfcdc76a214710ba69a7678e2a8959
record_format dspace
spelling oai:doaj.org-article:f4bfcdc76a214710ba69a7678e2a89592021-11-18T07:47:47ZPrevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study.1932-620310.1371/journal.pone.0063034https://doaj.org/article/f4bfcdc76a214710ba69a7678e2a89592013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23638179/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Aim</h4>The aim of this study was to assess the prevalence and patterns of exposure to antidepressants before, during and after pregnancy in a cohort including all pregnant women in Denmark between 1997 and 2010.<h4>Methods</h4>We performed a retrospective cohort study including 912 322 pregnancies. Information was retrieved from the Danish Birth Registry and The Register of Medicinal Product Statistics to identify women redeeming an antidepressant prescription during pregnancy. Exposure periods were based on standard treatment doses and dispensed pack sizes.<h4>Results</h4>We identified 19 740 pregnancies exposed to an antidepressant at some point during pregnancy. The rate of exposure increased from 0.2% in 1997 to 3.2% in 2010. We found that the rate of exposure was halved during the first 3 months of pregnancy. In contrast, we describe a clear increase in exposure after pregnancy among pre-delivery treatment-naïve women.<h4>Conclusions</h4>In spite of uncertainty concerning antidepressants' safety during pregnancy we find a 16-fold increase in exposure rates between 1997 and 2010. The rates describe a sharp decrease in exposure during pregnancy that is probably caused by physicians' hesitation to prescribe antidepressants and women's fear of unwanted effects on the unborn child. More studies are needed to clarify the consequences of antidepressant discontinuation during pregnancy.Espen Jimenez-SolemJon Trærup AndersenMorten PetersenKasper BroedbaekNadia Lyhne AndersenChristian Torp-PedersenHenrik Enghusen PoulsenPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 4, p e63034 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Espen Jimenez-Solem
Jon Trærup Andersen
Morten Petersen
Kasper Broedbaek
Nadia Lyhne Andersen
Christian Torp-Pedersen
Henrik Enghusen Poulsen
Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study.
description <h4>Aim</h4>The aim of this study was to assess the prevalence and patterns of exposure to antidepressants before, during and after pregnancy in a cohort including all pregnant women in Denmark between 1997 and 2010.<h4>Methods</h4>We performed a retrospective cohort study including 912 322 pregnancies. Information was retrieved from the Danish Birth Registry and The Register of Medicinal Product Statistics to identify women redeeming an antidepressant prescription during pregnancy. Exposure periods were based on standard treatment doses and dispensed pack sizes.<h4>Results</h4>We identified 19 740 pregnancies exposed to an antidepressant at some point during pregnancy. The rate of exposure increased from 0.2% in 1997 to 3.2% in 2010. We found that the rate of exposure was halved during the first 3 months of pregnancy. In contrast, we describe a clear increase in exposure after pregnancy among pre-delivery treatment-naïve women.<h4>Conclusions</h4>In spite of uncertainty concerning antidepressants' safety during pregnancy we find a 16-fold increase in exposure rates between 1997 and 2010. The rates describe a sharp decrease in exposure during pregnancy that is probably caused by physicians' hesitation to prescribe antidepressants and women's fear of unwanted effects on the unborn child. More studies are needed to clarify the consequences of antidepressant discontinuation during pregnancy.
format article
author Espen Jimenez-Solem
Jon Trærup Andersen
Morten Petersen
Kasper Broedbaek
Nadia Lyhne Andersen
Christian Torp-Pedersen
Henrik Enghusen Poulsen
author_facet Espen Jimenez-Solem
Jon Trærup Andersen
Morten Petersen
Kasper Broedbaek
Nadia Lyhne Andersen
Christian Torp-Pedersen
Henrik Enghusen Poulsen
author_sort Espen Jimenez-Solem
title Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study.
title_short Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study.
title_full Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study.
title_fullStr Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study.
title_full_unstemmed Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study.
title_sort prevalence of antidepressant use during pregnancy in denmark, a nation-wide cohort study.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/f4bfcdc76a214710ba69a7678e2a8959
work_keys_str_mv AT espenjimenezsolem prevalenceofantidepressantuseduringpregnancyindenmarkanationwidecohortstudy
AT jontrærupandersen prevalenceofantidepressantuseduringpregnancyindenmarkanationwidecohortstudy
AT mortenpetersen prevalenceofantidepressantuseduringpregnancyindenmarkanationwidecohortstudy
AT kasperbroedbaek prevalenceofantidepressantuseduringpregnancyindenmarkanationwidecohortstudy
AT nadialyhneandersen prevalenceofantidepressantuseduringpregnancyindenmarkanationwidecohortstudy
AT christiantorppedersen prevalenceofantidepressantuseduringpregnancyindenmarkanationwidecohortstudy
AT henrikenghusenpoulsen prevalenceofantidepressantuseduringpregnancyindenmarkanationwidecohortstudy
_version_ 1718422948745838592